USPTO 2015–2025 USPTO PatentsView US Corporation

Pivot Bio, Inc.

USPTO PatentsView assignee record - 17 granted patents across 15 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

30.6

Avg claims per patent

+650%

5-year filing velocity

The verdict

Pivot holds 17 US patents across 15 technology areas, rank #17,096 of 50,000 tracked assignees.

#17,096
of 50,000 US assignees by volume: Top 13%
by Innovation Score (50.3/100): 30.6
avg claims per patent: +650%
filing velocity, last 5 yrs

Portfolio overview

Pivot Bio, Inc. has been granted 17 US utility patents between 2018 and 2025, placing Pivot Bio, Inc. at rank #17,096 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 30.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Pivot Bio, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Pivot sits between Philips North America Llc (17 patents, rank #17,092) and Porsche Lizenz- Und Handelsgesellschaft Mbh & Co. KG (17 patents, rank #17,100) - the closest US assignees by grant volume. The composite Innovation Score of 50.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 2 in the 2015–2019 window, a +650% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Pivot Bio, Inc.'s 30.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Pivot Bio, Inc. against peers pursuing similar technology classes.

Philips North Ame…

17
Phoenix Products

17
Phonak

17
Piotech

17
Placon

17
Polar Semiconduct…

17
Polaris Capital

17
Porsche Lizenz- u…

17
Pivot Bio ◀

17

What this shows Pivot holds 17 patents at rank #17,096, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pivot

By rank, the assignees closest to #17,096 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Pivot's primary technology class.

Pivot's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Pivot Bio, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	5.9%
2019	1	5.9%
2020	1	5.9%
2021	2	11.8%
2023	4	23.5%
2024	3	17.6%
2025	5	29.4%

Which technologies does Pivot Bio, Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 11

C12Y - ENZYMES 9

C05F - ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE 9

C07K - PEPTIDES 9

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 8

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 8

C05C - NITROGENOUS FERTILISERS 7

A01P - BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS 5

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 4

A01H - NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 3

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

A01G - HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

Y02W - CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT 1

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 1

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#17,096

Across all tracked assignees

Innovation Score

50.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Pivot Bio, Inc. hold?

Pivot Bio, Inc. holds 17 US granted patents filed between 2018 and 2025, spanning 15 technology areas.

What is Pivot Bio, Inc.'s Innovation Score?

Pivot Bio, Inc. has an Innovation Score of 50.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pivot Bio, Inc. focus on?

Pivot Bio, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 11 patents. The company has filed patents in 15 CPC subclasses total.

Is Pivot Bio, Inc.'s patent filing rate increasing or decreasing?

Pivot Bio, Inc.'s recent filing velocity is +650% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Pivot Bio, Inc.'s patents?

Pivot Bio, Inc.'s patents average 30.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Pivot Bio, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Pivot's 17 grants land it in the top 13% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Pivot ranks #17,096 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.